RPRD1A Antikörper (AA 231-312) (Cy5)
Kurzübersicht für RPRD1A Antikörper (AA 231-312) (Cy5) (ABIN913982)
Target
Alle RPRD1A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 231-312
-
Homologie
- Human,Mouse,Rat,Cow,Pig,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human RPRD1A/P15RS
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- RPRD1A (Regulation of Nuclear Pre-mRNA Domain Containing 1A (RPRD1A))
-
Andere Bezeichnung
- RPRD1A
-
Hintergrund
-
Synonyms: Cyclin dependent kinase 2B inhibitor related protein, Cyclin dependent kinase inhibitor 2B related protein p15INK4B related protein, Cyclin dependent kinase inhibitor 2B related protein, Cyclin dependent kinase inhibitor related protein, Hypothetical protein FLJ10656, p15INK4B related protein, Putative uncharacterized protein P15RS, Regulation of nuclear pre mRNA domain containing 1A, RPRD1A, RPR1A_HUMAN.
Background: P15RS is upregulated in cells overexpressing cyclin-dependent kinase inhibitor p15(INK4b) (CDKN2B, MIM 600431) and may have a role in cell cycle regulation
Target
-